ReviewOncology research2020
Anticancer Activity of Novel NF-kappa B Inhibitor DHMEQ by Intraperitoneal Administration.
Kazuo Umezawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it
ReviewOncology research2020
Kazuo Umezawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.